Παρακολούθηση
charlotte martin
charlotte martin
vrije universiteit brussel
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα vub.be
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Silicon-containing amino acids: synthetic aspects, conformational studies, and applications to bioactive peptides
E Rémond, C Martin, J Martinez, F Cavelier
Chemical Reviews 116 (19), 11654-11684, 2016
2902016
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists
T Claff, J Yu, V Blais, N Patel, C Martin, L Wu, GW Han, BJ Holleran, ...
Science advances 5 (11), eaax9115, 2019
1132019
Controlled-release of opioids for improved pain management
C Martin, A De Baerdemaeker, J Poelaert, A Madder, R Hoogenboom, ...
Materials Today 19 (9), 491-502, 2016
762016
Solvent-free synthesis of hydrazones and their subsequent N-alkylation in a Ball-mill
P Nun, C Martin, J Martinez, F Lamaty
Tetrahedron 67 (42), 8187-8194, 2011
722011
Anti-human PD-L1 nanobody for immuno-PET imaging: validation of a conjugation strategy for clinical translation
J Bridoux, K Broos, Q Lecocq, P Debie, C Martin, S Ballet, G Raes, S Neyt, ...
Biomolecules 10 (10), 1388, 2020
622020
A bifunctional-biased mu-opioid agonist–neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects
AD La Rochelle, K Guillemyn, M Dumitrascuta, C Martin, V Utard, ...
Pain 159 (9), 1705-1718, 2018
412018
Injectable peptide hydrogels for controlled-release of opioids
C Martin, E Oyen, J Mangelschots, M Bibian, TB Haddou, J Andrade, ...
MedChemComm 7 (3), 542-549, 2016
392016
In Vivo Imaging of the Stability and Sustained Cargo Release of an Injectable Amphipathic Peptide-Based Hydrogel
E Oyen, C Martin, V Caveliers, A Madder, B Van Mele, R Hoogenboom, ...
Biomacromolecules 18 (3), 994-1001, 2017
362017
Injectable peptide-based hydrogel formulations for the extended in vivo release of opioids
C Martin, E Oyen, Y Van Wanseele, TB Haddou, H Schmidhammer, ...
Materials Today Chemistry 3, 49-59, 2017
352017
Biodegradable amphipathic peptide hydrogels as extended-release system for opioid peptides
C Martin, M Dumitrascuta, M Mannes, A Lantero, D Bucher, K Walker, ...
Journal of medicinal chemistry 61 (21), 9784-9789, 2018
342018
Silaproline Helical Mimetics Selectively Form an All‐trans PPII Helix
C Martin, B Legrand, A Lebrun, D Berthomieu, J Martinez, F Cavelier
Chemistry–A European Journal 20 (44), 14240-14244, 2014
332014
The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis
LA Rosado, K Wahni, G Degiacomi, B Pedre, D Young, AG De la Rubia, ...
Journal of Biological Chemistry 292 (32), 13097-13110, 2017
322017
Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis–impact of radiochemistry on pharmacokinetics
G Bala, M Crauwels, A Blykers, I Remory, ALJ Marschall, S Dübel, ...
Biological chemistry 400 (3), 323-332, 2019
282019
Peptide-based targeting of connexins and pannexins for therapeutic purposes
A Caufriez, D Böck, C Martin, S Ballet, M Vinken
Expert opinion on drug discovery 15 (10), 1213-1222, 2020
252020
Optimized opioid-neurotensin multitarget peptides: from design to structure–activity relationship studies
S Gonzalez, M Dumitrascuta, E Eiselt, S Louis, L Kunze, A Blasiol, ...
Journal of medicinal chemistry 63 (21), 12929-12941, 2020
252020
Neurotensin analogues containing cyclic surrogates of tyrosine at position 11 improve NTS2 selectivity leading to analgesia without hypotension and hypothermia
E Eiselt, S Gonzalez, C Martin, M Chartier, C Betti, JM Longpré, F Cavelier, ...
ACS Chemical Neuroscience 10 (11), 4535-4544, 2019
252019
Zn-catalyzed nicotinate-directed transamidations in peptide synthesis
C Hollanders, E Renders, C Gadais, D Masullo, L Van Raemdonck, ...
ACS Catalysis 10 (7), 4280-4289, 2020
242020
Wandering beyond small molecules: peptides as allosteric protein modulators
M Mannes, C Martin, C Menet, S Ballet
Trends in Pharmacological Sciences 43 (5), 406-423, 2022
232022
Development of potent and proteolytically stable human neuromedin U receptor agonists
A De Prins, C Martin, Y Van Wanseele, LJ Skov, C Tömböly, D Tourwé, ...
European journal of medicinal chemistry 144, 887-897, 2018
202018
Site-Specific radioactive labeling of nanobodies
M Crauwels, S Massa, C Martin, C Betti, S Ballet, N Devoogdt, C Xavier, ...
Antibody Engineering: methods and protocols, 505-540, 2018
172018
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20